Evaluation of management of Graves' disease in District General Hospital: achievement of consensus guidelines.
The management of Graves' disease in a District General Hospital was audited. A local care pathway was designed, which was inclusive of diagnosis, treatment and follow-up. This was then compared with consensus guidelines proposed by the Royal College of Physicians. Forty-six patients with Graves' disease attended the endocrine clinic. The diagnosis was based on clinical and biochemical features of autoimmune thyrotoxicosis, a raised thyroid-stimulating hormone receptor antibody (TRAB) and a diffusely increased uptake in thyroid technetium scan. They were treated for 18 months with antithyroid medications, which was subsequently discontinued provided satisfactory euthyroid state was achieved. Patients were followed up to assess remission and relapse status. The audit suggested that care pathway was in keeping with the guidelines. A few excess TRAB tests were requested. The relapse rate was 42% in our series and one-third of them (33%) chose to continue medical therapy.
Dasgupta
S
S
Department of General Medicine, Bury General Hospital, Bury, Lancashire, UK. sanghamitra_us@yahoo.com
Savage
M W
MW
D013956:Antithyroid Agents / Q000627:therapeutic use*; D006111:Graves Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000628:therapy; D019983:Guideline Adherence; D006767:Hospitals, District; D006769:Hospitals, General; D006801:Humans; D008485:Medical Audit / Q000379:methods*; D010865:Pilot Projects; D017410:Practice Guidelines as Topic; D012008:Recurrence
D013956:Antithyroid Agents